)
Edge20 Mar 2026
Tetra Pak: The Shape of Innovation
The story of Tetra Pak, the Rausing family, and how a paper tetrahedron gave rise to a company that now delivers almost 180 billion packages a year.
Theralase Technologies
Theralase Technologies (TLT) investor relations material
Theralase Technologies Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary10 Nov, 2025
Executive summary
Revenue for the nine months ended September 30, 2025, decreased 5% year-over-year to $590,573, with a net loss increasing 3% to $3,435,145.
Gross margin remained stable at $290,830, representing 49% of revenue.
Operational focus included advancing Study II, nearing full enrollment, and reporting promising interim clinical results.
Financial highlights
Total revenue declined 5% to $590,573 from $622,984 year-over-year.
Cost of sales decreased 10% to $299,743, improving as a percentage of revenue.
Gross margin was $290,830 (49% of revenue), nearly unchanged from the prior year.
Net loss increased 3% to $3,435,145, including $708,521 in non-cash charges.
Research and development expenses rose 1% to $2,116,540, supporting Study II progress.
Outlook and guidance
Study II enrollment expected to complete in 4Q2025, with data lock and regulatory submissions targeted for 1Q2027.
Company continues to seek additional equity and non-dilutive funding to support clinical and commercial milestones.
Elaborate on 450-day CR durability impact
Strategy for high-interest short-term loans
Explain US and International revenue decline
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Theralase Technologies
- Patented therapies show strong efficacy in cancer and HSV, targeting major global markets.TLT
Corporate presentation24 Mar 2026 - Net loss narrowed 7% as strong clinical data and pipeline progress drive future plans.TLTQ4 202426 Dec 2025
- Revenue dropped and losses widened as late-stage drug trials advance and new funding is sought.TLTQ1 202524 Nov 2025
- Revenue up 12% but net loss persists; heavy R&D spend and going concern risks remain.TLTQ2 202523 Sep 2025
Next Theralase Technologies earnings date
Q4 20253 Apr, 2026
Theralase Technologies
Next Theralase Technologies earnings date
Q4 20253 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage